4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-002829
Chief Financial Officer acquired 521 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Downs Christopher Chief Financial Officer | 2023-04-28 | Option exercise | +521 | 9,772 | D | ||
| Derivatives | |||||||
| Downs Christopher Chief Financial Officer | 2023-04-28 | Option exercise · Restricted Stock Units | −521 | 28,248 | D | ||
Loading xslF345X04/ownership.xml…